New scope procedure may replace surgery for early colon cancer
NCT ID NCT06940947
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a new, less invasive treatment called endoscopic full-thickness resection (eFTR) to standard surgery for early colon cancer. About 434 adults with small, early-stage colon tumors will be randomly assigned to one of the two treatments. The goal is to see if eFTR is as safe and effective as surgery, with fewer side effects and a lower chance of cancer coming back.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of Gdańsk
RECRUITINGGdansk, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital nurse companion: could an app ease the burden of chronic illness?
- Can artificial intelligence think like a cancer tumor board?
- A new clue in the fight against colorectal cancer recurrence?
- Can radiation plus immunotherapy make colon tumors disappear before surgery?
- Can a chemo boost outsmart lingering colon cancer cells?
- Does practice make perfect? a study probes how a Surgeon's learning curve impacts cancer surgery success